• we cover more than 1,000 news per day, in 2 languages, and 83,000 stocks
Light Dark
it
italian it
english en

SYRS Investors Have Opportunity to Join Syros Pharmaceuticals, Inc. Securities Fraud Investigation with the Schall Law Firm

www.businesswire.com 21-08-2024 01:11 0.5 Minutes reading
LOS ANGELES--(BUSINESS WIRE)--SYRS Investors Have Opportunity to Join Syros Pharmaceuticals, Inc. Securities Fraud Investigation with the Schall Law Firm

Info